Bovine serum-derived immunoglobulin (Johns Hopkins Bloomberg School of Public Health)
N/A
Report date: 2022/07/19 20:00:45
Base Information
Drug NameBovine serum-derived immunoglobulin (Johns Hopkins Bloomberg School of Public Health)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins Bloomberg School Of Public HealthUnited States Department Of DefenseNaval Medical Research Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNaval Medical Research CenterJohns Hopkins Bloomberg School Of Public HealthUnited States Department Of Defense
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A